日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer

Wnt通路基因改变在晚期前列腺癌患者中的临床意义

Broderick, Amanda; Pan, Elizabeth; Li, Jinju; Chu, Alec; Hwang, Clara; Barata, Pedro C; Cackowski, Frank Cameron; Labriola, Matthew; Ghose, Alyssa; Bilen, Mehmet Asim; Kilari, Deepak; Thapa, Bicky; Piero, Michael; Graham, Laura; Tripathi, Abhishek; Garje, Rohan; Koshkin, Vadim S; Hernandez, Erik; Dorff, Tanya B; Schweizer, Michael Thomas; Alva, Ajjai Shivaram; McKay, Rana R; Armstrong, Andrew J

Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration

晚期前列腺癌中雄激素受体(AR)改变的临床意义:一项多中心合作研究

Zengin, Zeynep B; Henderson, Nicholas C; Park, Joseph J; Ali, Alicia; Nguyen, Charles; Hwang, Clara; Barata, Pedro C; Bilen, Mehmet A; Graham, Laura; Mo, George; Kilari, Deepak; Tripathi, Abhishek; Labriola, Matthew; Rothstein, Shoshana; Garje, Rohan; Koshkin, Vadim S; Patel, Vaibhav G; Schweizer, Michael T; Armstrong, Andrew J; McKay, Rana R; Alva, Ajjai; Dorff, Tanya

Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study

在FGFR3改变的晚期尿路上皮癌中,厄达替尼在恩福妥单抗治疗之前或之后的疗效:UNITE合作研究分析

Jiang, Cindy Y; Hwang, Hyunsoo; Epstein, Ilana Y; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Taylor, Amy K; Nizam, Amanda; Jindal, Tanya; Glover, Michael J; Khaki, Ali Raza; Barata, Pedro C; Nguyen, Charles B; Oh, Eugene; Davis, Nancy B; Mabey, Hannah; Hoimes, Christopher J; Evans, Sean T; Abuqayas, Bashar; Lemke, Emily; Tsung, Irene; Qiao, Wei; Kilari, Deepak; Zakharia, Yousef; Bilen, Mehmet A; Milowsky, Matthew I; Shah, Sumit A; Gupta, Shilpa; Emamekhoo, Hamid; Bellmunt, Joaquim; Alva, Ajjai S; Grivas, Petros; Msaouel, Pavlos; Koshkin, Vadim S; Campbell, Matthew T; Alhalabi, Omar

Genomic alterations and associated outcomes in patients with PSMA-positive metastatic castration-resistant prostate cancer treated with 177Lu-PSMA-617

接受 177Lu-PSMA-617 治疗的 PSMA 阳性转移性去势抵抗性前列腺癌患者的基因组改变及相关结局

Panian, Justine; Henderson, Nicholas C; Herchenhorn, Daniel; Barata, Pedro C; Bilen, Mehmet Asim; Graham, Laura; Heath, Elisabeth; Hwang, Clara; Supernois, Avery; Kilari, Deepak; Thapa, Bicky; Koshkin, Vadim S; Jindal, Tanya; Nauseef, Jones T; Sokolova, Alexandra; Amery, Taylor; Zakharia, Yousef; Schweizer, Michael T; Raychaudhuri, Ruben; Reichert, Zachery R; Dorff, Tanya; Armstrong, Andrew J; Wang, John; Alva, Ajjai; McKay, Rana R

Evaluating the reliability of large language models for clinical data extraction in bladder cancer prognosis

评估大型语言模型在膀胱癌预后临床数据提取中的可靠性

Sun, Di; Hadjiiski, Lubomir; Bruno, Grace; Gormley, John; Chan, Heang-Ping; Caoili, Elaine M; Cohan, Richard H; Alva, Ajjai; Mihalcea, Rada; Zhou, Chuan; Gulani, Vikas

Evaluating PSA dynamics for predicting androgen deprivation failure with a patient specific prostate cancer model.

利用患者特异性前列腺癌模型评估 PSA 动态变化以预测雄激素剥夺治疗失败

Zhao Shengchao, Keller Evan T, Robinson Tyler, Dai Jinlu, Ghose Alyssa, Alva Ajjai, Jackson Trachette, Jain Harsh Vardhan

Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study

接受恩福妥单抗治疗的晚期尿路上皮癌患者的治疗相关不良事件及相关结局:UNITE 研究分析

Nizam, Amanda; Nguyen, Charles B; Li, Jinju; Zabor, Emily C; Msaouel, Pavlos; Jiang, Cindy Y; Alhalabi, Omar; Oh, Eugene; Davidsohn, Matthew P; Epstein, Ilana B; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Jindal, Tanya; Taylor, Amy K; Glover, Michael J; Khaki, Ali Raza; Lemke, Emily; Mabey, Hannah; Abuqayas, Bashar; Jang, Albert; Brown, Jason R; Evans, Sean T; Pywell, Cameron; Basu, Arnab; Bilen, Mehmet A; Barata, Pedro C; Zakharia, Yousef; Milowsky, Matthew I; Kilari, Deepak; Hoimes, Christopher J; Shah, Sumit A; Emamekhoo, Hamid; Davis, Nancy B; Gupta, Shilpa; Grivas, Petros; Bellmunt, Joaquim; Campbell, Matthew T; Alva, Ajjai S; Koshkin, Vadim S

Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer

肌层浸润性膀胱癌的标准或扩大淋巴结切除术

Lerner, Seth P; Tangen, Catherine; Svatek, Robert S; Daneshmand, Siamak; Pohar, Kamal S; Skinner, Eila; Schuckman, Anne; Sagalowsky, Arthur I; Smith, Norm D; Kamat, Ashish M; Kassouf, Wassim; Plets, Melissa; Bangs, Rick; Koppie, Theresa M; Alva, Ajjai; La Rosa, Francisco G; Pal, Sumanta K; Kibel, Adam S; Canter, Daniel J; Thompson, Ian M Jr

Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma

S1500研究的最终总生存期分析:一项比较舒尼替尼与卡博替尼、克唑替尼和沙伐替尼治疗晚期乳头状肾细胞癌的随机II期研究

Barata, Pedro; Tangen, Catherine; Plets, Melissa; Thompson, Ian M Jr; Narayan, Vivek; George, Daniel J; Heng, Daniel Y C; Shuch, Brian; Stein, Mark; Gulati, Shuchi; Tretiakova, Maria; Tripathi, Abhishek; Bjarnason, Georg A; Humphrey, Peter; Adeniran, Adebowale; Vaishampayan, Ulka; Alva, Ajjai; Zhang, Tian; Cole, Scott; Lara, Primo N Jr; Lerner, Seth P; Balzer-Haas, Naomi; Pal, Sumanta K

Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer

在COXEN联合新辅助化疗治疗肌层浸润性膀胱癌的II期研究中,分子亚型与病理反应、无进展生存期(PFS)和总生存期(OS)的相关性

Lerner, Seth P; McConkey, David J; Tangen, Catherine M; Meeks, Joshua J; Flaig, Thomas W; Hua, Xing; Daneshmand, Siamak; Alva, Ajjai Shivaram; Lucia, M Scott; Theodorescu, Dan; Goldkorn, Amir; Milowsky, Matthew I; Choi, Woonyoung; Bangs, Rick; Gustafson, Daniel L; Plets, Melissa; Thompson, Ian M Jr